Literature DB >> 31072504

Critical Appraisal of Contemporary Clinical Endpoint Definitions in Coronary Intervention Trials: A Guidance Document.

Ernest Spitzer1, Eugene McFadden2, Pascal Vranckx3, Hector M Garcia-Garcia4, Jonathan H Seltzer5, Claes Held6, Ton de Vries7, Venu Menon8, Kimberly J Brown9, Osama I I Soliman1, Yoshinobu Onuma1, Renato D Lopes10, Gregg W Stone11, Donald E Cutlip12, Patrick W Serruys13.   

Abstract

The Academic Research Consortium (ARC) and the Standardized Data Collection for Cardiovascular Trials Initiative have recently published updated clinical and angiographic endpoint definitions for percutaneous coronary intervention trials. The aim of this document is to provide practical guidance to facilitate and harmonize the implementation of those definitions in randomized trials or registries, as well as to foster consistency among independent adjudication committees. The authors compared the ARC-2 and Standardized Data Collection for Cardiovascular Trials Initiative definitions to identify areas of consistency, complex scenarios, and definitions in need of further standardization. Furthermore, the authors compared the fourth universal definition of myocardial infarction with the ARC-2 definition of myocardial infarction. The Society for Cardiovascular Angiography and Interventions definition of periprocedural myocardial infarction was also compared with the ARC-2 definition and the fourth universal definition of myocardial infarction. An in-depth assessment was done for each individual clinical endpoint to guide clinical investigators on reporting and classifying clinical adverse events. Finally, the authors propose standard streamlined data capture templates for reporting and adjudicating death, myocardial infarction, stroke, revascularization, stent or scaffold thrombosis, and bleeding.
Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  bleeding; clinical endpoint adjudication; clinical endpoint definition; death; myocardial infarction; revascularization; scaffold thrombosis; stent thrombosis; stroke

Mesh:

Year:  2019        PMID: 31072504     DOI: 10.1016/j.jcin.2018.12.031

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  3 in total

1.  A multi-center, international, randomized, 2-year, parallel-group study to assess the superiority of IVUS-guided PCI versus qualitative angio-guided PCI in unprotected left main coronary artery (ULMCA) disease: Study protocol for OPTIMAL trial.

Authors:  Giovanni Luigi De Maria; Luca Testa; Jose M de la Torre Hernandez; Dimitrios Terentes-Printzios; Maria Emfietzoglou; Roberto Scarsini; Francesco Bedogni; Ernest Spitzer; Adrian Banning
Journal:  PLoS One       Date:  2022-01-07       Impact factor: 3.240

2.  Sleep apnea and diabetes mellitus are independently associated with cardiovascular events and hospitalization for heart failure after coronary artery bypass grafting.

Authors:  Aye-Thandar Aung; Chieh-Yang Koo; Wilson W Tam; Zhengfeng Chen; William Kristanto; Hui-Wen Sim; Pipin Kojodjojo; Theodoros Kofidis; Chi-Hang Lee
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

Review 3.  Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium.

Authors:  David E Kandzari; Felix Mahfoud; Michael A Weber; Raymond Townsend; Gianfranco Parati; Naomi D L Fisher; Melvin D Lobo; Michael Bloch; Michael Böhm; Andrew S P Sharp; Roland E Schmieder; Michel Azizi; Markus P Schlaich; Vasilios Papademetriou; Ajay J Kirtane; Joost Daemen; Atul Pathak; Christian Ukena; Philipp Lurz; Guido Grassi; Martin Myers; Aloke V Finn; Marie-Claude Morice; Roxana Mehran; Peter Jüni; Gregg W Stone; Mitchell W Krucoff; Paul K Whelton; Konstantinos Tsioufis; Donald E Cutlip; Ernest Spitzer
Journal:  Circulation       Date:  2022-03-14       Impact factor: 29.690

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.